GH Guardant Health Inc

Price (delayed)

$149.91

Market cap

$14.99B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.92

Enterprise value

$14.88B

Sector: Healthcare
Industry: Diagnostics & Research

Highlights

Guardant Health's quick ratio has soared by 76% YoY and by 4.4% from the previous quarter
The gross profit has soared by 53% YoY and by 6% from the previous quarter
GH's equity is up by 34% YoY but it is down by 2% QoQ
Guardant Health's net income has shrunk by 145% YoY and by 54% QoQ
The EPS has dropped by 50% since the previous quarter

Key stats

What are the main financial stats of GH
Market
Shares outstanding
99.97M
Market cap
$14.99B
Enterprise value
$14.88B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
13.65
Price to sales (P/S)
55.01
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
54.86
Earnings
Revenue
$271.31M
EBIT
-$185.27M
EBITDA
-$164.81M
Free cash flow
-$128.84M
Per share
EPS
-$1.92
Free cash flow per share
-$1.29
Book value per share
$10.99
Revenue per share
$2.73
TBVPS
$12.48
Balance sheet
Total assets
$1.26B
Total liabilities
$113.51M
Debt
$39.68M
Equity
$1.09B
Working capital
$1.02B
Liquidity
Debt to equity
0.04
Current ratio
15.11
Quick ratio
14.59
Net debt/EBITDA
0.63
Margins
EBITDA margin
-60.7%
Gross margin
68.3%
Net margin
-68.3%
Operating margin
-69.9%
Efficiency
Return on assets
-16.7%
Return on equity
-19.5%
Return on invested capital
-20.5%
Return on capital employed
-15.6%
Return on sales
-68.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GH stock price

How has the Guardant Health stock price performed over time
Intraday
0%
1 week
-8.22%
1 month
12.05%
1 year
92.54%
YTD
16.32%
QTD
16.32%

Financial performance

How have Guardant Health's revenue and profit performed over time
Revenue
$271.31M
Gross profit
$185.35M
Operating income
-$189.75M
Net income
-$185.25M
Gross margin
68.3%
Net margin
-68.3%
Guardant Health's net income has shrunk by 145% YoY and by 54% QoQ
GH's operating income has plunged by 126% YoY and by 43% from the previous quarter
The net margin has dropped by 67% year-on-year and by 46% since the previous quarter
The company's operating margin has shrunk by 54% YoY and by 35% QoQ

Growth

What is Guardant Health's growth rate over time

Valuation

What is Guardant Health stock price valuation
P/E
N/A
P/B
13.65
P/S
55.01
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
54.86
The EPS has dropped by 50% since the previous quarter
The P/B is 57% more than the last 4 quarters average of 8.7
GH's equity is up by 34% YoY but it is down by 2% QoQ
The P/S is 68% above the last 4 quarters average of 32.8
Guardant Health's revenue has increased by 47% YoY and by 5% from the previous quarter

Efficiency

How efficient is Guardant Health business performance
GH's ROA has dropped by 69% year-on-year and by 44% since the previous quarter
The ROE has plunged by 67% YoY and by 42% from the previous quarter
The return on sales has dropped by 66% year-on-year and by 46% since the previous quarter
Guardant Health's ROIC has decreased by 46% YoY and by 39% from the previous quarter

Dividends

What is GH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GH.

Financial health

How did Guardant Health financials performed over time
Guardant Health's quick ratio has soared by 76% YoY and by 4.4% from the previous quarter
GH's current ratio has surged by 76% year-on-year and by 4.8% since the previous quarter
The debt is 96% smaller than the equity
GH's equity is up by 34% YoY but it is down by 2% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.